Creatine is the most-studied molecule in sports nutrition. But behind the muscle story, another one is taking shape: that of a cerebral energy buffer that may, in part, blunt the cognitive toll of a sleepless night. Here is a 2026 update on what the evidence actually says — and what it doesn’t.
From muscle to brain: why creatine matters for neuroscience
Creatine isn’t just a substrate for muscular performance. It sits at the heart of the phosphocreatine ↔ ATP system, the « energy buffer » that regenerates ATP within milliseconds wherever demand spikes. The brain — only 2% of body weight but consuming nearly 20% of the body’s total energy — runs on exactly this principle. The most energy-hungry regions (prefrontal cortex, hippocampus) are also the most sensitive to drops in energy availability.
Under sleep deprivation, the brain enters a state of measurable « energy stress » — visible in phosphorus-31 NMR spectroscopy: drop in phosphocreatine, rise in inorganic phosphate, drop in ATP, cellular acidification. This imbalance underlies the well-known fall in attention, slowed reaction times, and the executive and emotional difficulties everyone experiences after a sleepless night.
💡 Key takeaways
- Creatine fuels the phosphocreatine ↔ ATP buffer, essential for energy-hungry tissues: muscle, brain, heart.
- Acute sleep deprivation disrupts cerebral bioenergetics, particularly in the right hemisphere during the second half of the night.
- A single high dose (0.2 to 0.35 g/kg body weight) can raise cerebral creatine stores within hours and blunt the cognitive decline — up to +12% on certain tasks.
- Effects are modest, partial, and do not replace sleep.
What the evidence shows in 2024–2026
1. The Gordji-Nejad pivotal study (Scientific Reports, 2024)
The pivotal study by Gordji-Nejad et al., published in Scientific Reports (Nature Portfolio) in 2024, marked a turning point. During a 21-hour sleep deprivation protocol, a single high oral dose of creatine monohydrate (0.35 g/kg) induced — as measured by 31P-MRS — an increase in the PCr/Pi ratio, ATP stabilization, pH maintenance, and significant improvements in cognitive performance and processing speed. This was the first in vivo demonstration that a single intake — not just multi-week chronic supplementation — can have a measurable brain effect.
2. Confirmation at lower doses (Nutrients, 2026)
The follow-up study published in Nutrients in 2026, in 29 subjects, confirmed that a more modest dose (0.2 g/kg) already mitigates cognitive deterioration (logic, numeric, language and psychomotor vigilance tasks), with improvements reaching 12%. The effect is smaller than at 0.35 g/kg but remains clinically perceptible. Women appear to benefit more in logic and processing-speed tasks.
3. The mechanism: hemispheric asymmetry (Frontiers in Neuroscience, 2025)
A reanalysis published in Frontiers in Neuroscience (2025) showed that sleep deprivation affects the right hemisphere more (steeper ATP drop). Creatine rebalances this asymmetry, primarily through elevation of PCr/Pi in the left hemisphere. This gives the phenomenon a mechanistic signature, beyond mere symptomatic improvement.
4. The Xu et al. meta-analysis on cognition (Frontiers in Nutrition, 2024)
The meta-analysis by Xu et al. (Frontiers in Nutrition, 2024, 16 RCTs, 492 participants) concluded a positive and significant effect on memory, attention and processing speed, with a clearer benefit in clinically stressed individuals, those aged 18–60, and women. By contrast, in young healthy adults under normal conditions, the benefit is marginal. This is one of the key messages: creatine is not a general « cognitive enhancer » — it’s a resilience tool under energy stress.
5. Creatine and mood: cautious interpretation (BJN, 2025)
A recent meta-analysis in the British Journal of Nutrition (2025, 11 trials, 1,093 participants) on creatine and depression concluded a « small-to-moderate » effect, not systematically clinically significant, with low evidence quality. Bottom line: yes, a favorable signal on « brain fog » and mood, but the average effect falls below the clinical relevance threshold, and the literature shows a bias in favor of creatine. Cautious interpretation warranted.
Dosing protocols: what actually works
| Protocol | Dose | Use case | Evidence level |
|---|---|---|---|
| Standard maintenance | 3–5 g/day, continuous | Long-term baseline, muscle + brain | 🟢 Strong |
| Loading phase | 20 g/day in 4 doses for 5–7 days, then 3–5 g/day | Faster store saturation | 🟢 Strong |
| Acute single dose (research) | 0.2–0.35 g/kg body weight | Announced sleep deprivation (shift, travel, exam) | 🟡 Emerging |
- Best-documented form: creatine monohydrate. « Advanced » forms (HCl, malate, kre-alkalyn) have not demonstrated superiority in practice.
- Timing: ideally with a meal. Cerebral effect of a single high dose: detectable within 3–7 hours, peak at ~4h, lasting up to 9h.
- Caution at high doses: gastrointestinal discomfort is common. High doses belong to the research context, not daily use.
⚠️ Weak signals — proceed with caution
- Creatine does not replace sleep. No supplement reproduces glymphatic clearance, memory consolidation, hormonal and immune regulation, or synaptic repair — all sleep-specific.
- Effects are modest and contextual: they truly appear only under energy stress (acute deprivation, hypoxia, intense mental fatigue). Outside stress conditions, cognitive benefit in healthy adults is small.
- Kidney function: creatine transiently elevates serum creatinine through metabolic turnover, without altering GFR in healthy subjects (2025 meta-analysis). But caution remains warranted in preexisting kidney disease.
- Hydration and possible mild water-weight gain (1–2 kg). Gastrointestinal upset at high doses.
- Real risk of slipping into a logic of « organizational doping »: using supplements to mask pathogenic work conditions (shift work, extended duty hours) without questioning the system itself.
What’s still missing in the evidence
Protocols vary enormously (dose, duration, total vs. partial deprivation, participant profiles). We still lack:
- Large real-world studies (shift work, hospital duty, ER, transportation, military);
- Long-term data on chronic supplementation in night-shift workers;
- Stratification by sex, nutritional status (vegetarians/vegans, who have lower creatine stores), and genotype of cerebral creatine transporters.
The NutriCellScience perspective
The creatine case perfectly illustrates a neuroenergetic and immunometabolic approach to health: you don’t « stimulate » a tired brain — you restore an energy reserve. Conceptually, this is different from — and more solid than — a classical nootropic. Creatine monohydrate combines three rare assets: measurable biological evidence (spectroscopy), excellent safety profile at standard doses, and very low cost.
That said, the reasonable position remains that of a supportive tool, not an antidote. Standard maintenance supplementation (3–5 g/day) in a healthy adult, with no renal contraindication, is defensible given the benefit/risk/cost ratio. An acute high-dose protocol in case of announced sleep deprivation (shift, travel, exam) is documented but remains experimental and gastrointestinally uncomfortable.
Sleep itself remains biologically irreplaceable. No supplement replicates the glymphatic clearance of neural waste, REM-stage memory consolidation, or nocturnal hormonal balance. Creatine can soften a rough patch; it does not rewrite physiology.
Primary references
- Gordji-Nejad A. et al. Single dose creatine improves cognitive performance and induces changes in cerebral high energy phosphates during sleep deprivation. Sci Rep. 2024;14:4937. nature.com · DOI: 10.1038/s41598-024-54249-9
- Gordji-Nejad A. et al. Single-Dose Creatine Reduces Sleep Deprivation-Induced Deterioration in Cognitive Performance. Nutrients. 2026;18(8):1192. mdpi.com · DOI: 10.3390/nu18081192
- Gordji-Nejad A. et al. Hemispheric asymmetry in high-energy phosphate consumption during sleep deprivation is balanced by creatine. Front Neurosci. 2025;19:1515761. frontiersin.org
- Xu C. et al. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Front Nutr. 2024;11:1424972. frontiersin.org
- Eckert I. et al. Creatine supplementation for treating symptoms of depression: a systematic review and meta-analysis. Br J Nutr. 2025. cambridge.org
- Kabiri Naeini E. et al. Effect of creatine supplementation on kidney function: a systematic review and meta-analysis. BMC Nephrol. 2025;26:225. bmcnephrol.biomedcentral.com
- Fabiano N., Candow D. Creatine Supplementation: More Is Likely Better for Brain Bioenergetics, Health and Function. J Phys Biomed Sci. 2025. jpbs.hapres.com
- Gonzalez D.E. et al. Fueling the Firefighter and Tactical Athlete with Creatine. Nutrients. 2024;16(19):3285. mdpi.com
Originally published in French on May 11, 2026. Read the French version here.
NutriCellScience, Mark DOWN — EN edition
Nutricellscience 
Laisser un commentaire